Exploratory Study Using a New Head-only PET Scanner
NCT04511546 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2021-03-10
Summary
The "BPET prototype" is a small aperture PET scanner. The BPET prototype will be used with patients, which have just finished their regularly scheduled PET examination on a clinical whole body PET system. The radioactive tracer used for this procedure will still be active. This remaining acitivity will be used for an image acquisition with the BPET prototype without the need for an additional radioactive tracer dose.
The control intervention is be a brain PET scan as part of standard clinical routine. It will be done immediately before the scan on the BPET prototype.
Conditions
- Brain Diseases
Interventions
- DEVICE
-
BPET Prototype Scan
Scan on the BPET Prototype PET system and qualitative comparison with a PET image acquired on a conventional clinical PET system.
Sponsors & Collaborators
-
University of Zurich
collaborator OTHER -
Positrigo AG
lead INDUSTRY
Principal Investigators
-
Martin Hüllner, PD Dr. med. · University of Zurich
Study Design
- Allocation
- NA
- Purpose
- DEVICE_FEASIBILITY
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-10-27
- Primary Completion
- 2021-03-05
- Completion
- 2021-03-05
Countries
- Switzerland
Study Locations
More Related Trials
-
Effectiveness in Head and Neck Cancer Detection Using Positron Emission Tomography (PET) Insert Device
NCT01133262 ·Status: WITHDRAWN
-
PET/MRI Perfusion and CT Perfusion in Solid Tumors
NCT02314962 ·Status: TERMINATED
-
Methionine and PBR28-PET (Peripheral Benzodiazepine Receptors) in Brain Metastases Following Radiosurgery
NCT02433171 ·Status: TERMINATED
-
Clinical Evaluation Of MP26 Features in Adults
NCT02927327 ·Status: COMPLETED ·Phase: NA
-
Demonstration Of A Next Generation PET CT System
NCT05122715 ·Status: UNKNOWN ·Phase: NA
-
FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions
NCT02328300 ·Status: WITHDRAWN
-
FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer
NCT01432002 ·Status: UNKNOWN
-
Assessing Ultra-low Dose PET/CT and CT-less PET Using a Long Axial Field-of-view PET/CT System
NCT05496920 ·Status: COMPLETED ·Phase: NA
-
PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations
NCT01089998 ·Status: COMPLETED ·Phase: PHASE1
-
Single-tracer Multiparametric PET Imaging
NCT06014515 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Clinical Application of the Prototype J-PET Device
NCT06211803 ·Status: COMPLETED
-
Application of the CD73-Targeted Probe ⁶⁸Ga-DOTA-mPNE PET/CT Imaging in the Diagnosis of Malignant Tumors
NCT07023640 ·Status: RECRUITING ·Phase: NA
-
A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
NCT02431572 ·Status: COMPLETED ·Phase: NA
-
Demonstration of the "SPECT/CT System With CZT Detectors" Imaging Performance in a Clinical Setting
NCT03229772 ·Status: COMPLETED ·Phase: NA
-
A Phase 1, Open-Label, PET Study of T2310 & BPN14770
NCT04044781 ·Status: WITHDRAWN ·Phase: PHASE1
-
68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients
NCT02327442 ·Status: UNKNOWN
-
Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer
NCT03100136 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
NCT05160480 ·Status: ENROLLING_BY_INVITATION
-
Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device
NCT02331381 ·Status: TERMINATED ·Phase: PHASE1
-
Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-4367 in Patients With Prostate Cancer and Healthy Volunteers
NCT00975299 ·Status: TERMINATED ·Phase: PHASE1
-
PET/CT Imaging of Malignant Brain Tumors With 124I-NM404
NCT01516905 ·Status: COMPLETED
-
PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents
NCT02325349 ·Status: TERMINATED ·Phase: PHASE2
-
A PET Study to Determine Biodistribution and Binding Characteristics of [11C]AZ14132516 in Healthy Participants
NCT05818514 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
NCT02247713 ·Status: UNKNOWN
-
PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
NCT02084147 ·Status: COMPLETED ·Phase: NA